Algenex and Global DX Agree to Develop Diagnostic Products for the Detection of African Swine Fever
Algenex SL, a private biotechnology company delivering disruptive technologies for recombinant biologics production, and Global DX Ltd, a company dedicated to improving the quality of animal care by facilitating accurate diagnosis for veterinarians worldwide, today announce that they have entered into an agreement to jointly develop and commercialize diagnostic products for the detection of African Swine Fever. The first product to be developed will be a point-of-care rapid diagnostic test to identify pigs who have been exposed to the African Swine Fever Virus (ASFV). The agreement is the first collaboration between the two companies and provides the framework for further co-developments across a potentially wide range of diagnostic areas.
Under the terms of the agreement, Algenex will deliver the diagnostic reagents and Global DX will provide the technical expertise to develop and manufacture the point-of-care rapid diagnostic tests. Both companies will collaborate in the distribution of...
To Read Full Story Login Below.
Submit comment or question
Note: All comments are displayed with user's screen name. If screen name is not present, user's full name will be used. Please go to My Account to update your screen name.
Comment Policy: Urner Barry has made the comment feature available to encourage further discussion of our news stories. Defamatory or offensive comments, or comments deemed not relevant to the story will be removed, and if necessary, Urner Barry may restrict the right of individual subscribers to offer comments. In all cases, comments represent opinions of the poster only, and do not represent fact, news, opinions or estimates put forward by Urner Barry.
Email Address is required.
Password is required.